Key result
Modern residual risk models enable more aggressive, individualized secondary preventive therapy to achieve guideline targets.
Why the study?
Patients surviving acute myocardial infarction or with atherosclerotic cardiovascular disease are at very high risk, requiring more aggressive treatment of risk factors and residual risk assessment.
Recognizing residual cardiovascular risk using modern assessment models provides orientation for more aggressive, individualized secondary preventive therapy to reach European guideline targets.
May support aggressive individualized secondary prevention via residual risk models; leaves open prospective validation before practice change.
Patients who have survived an acute myocardial infarction, as well as those with atherosclerotic cardiovascular disease, established or unequivocally confirmed by imaging techniques, represent a very high-risk group. This group of patients requires more aggressive treatment of risk factors, regular controls, and monitoring of the effect of therapy. The article aimed to point out the historical importance of risk factors and modern models for assessing residual risk by reviewing the literature. Recognizing the residual risk provides orientation and motivation for more aggressive implementation of secondary preventive therapy on an individual level in daily work with patients and the possibility of reaching the target values recommended by European guidelines.
No takes yet. Share an insight, caveat, or question.
Ivana Burazor (2024) conducted a review in Atherosclerotic cardiovascular disease. Secondary prevention and residual risk assessment models was evaluated. Recognizing residual cardiovascular risk and utilizing modern risk assessment models enables more aggressive, individualized secondary preventive therapy to achieve guideline-recommended target values.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: